Ledger.Open graph →
SEC Form D · filed August 31, 2021

SPR Therapeutics, Inc

Offering
$35.0M
Sold
$20.0M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
CLEVELAND, OH
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (27)

Nicholas J. Valeriani · Cleveland, OHDirectorGeoffrey B. Thrope · Cleveland, OHDirectorMaria E. Bennett · Cleveland, OHExec · DirectorMark C. Stulz · Cleveland, OHExecMichael C. Chuisano · Cleveland, OHDirectorRobert B. Blankenship · Cleveland, OHDirectorDave C. Youngberg · Cleveland, OHExecBen J. Austin · Cleveland, OHExecJosh C. Boggs · Cleveland, OHExecCarrie R. Sullivan · Purchase, NYDirectorMichael L. Boroson · Honeoye, NYExecJames T. Merkel · COLUMBUS, OHDirectorDavid C. Fox · College Station, TXDirectorKenneth J. Krebs · COLUMBUS, OHExecGreg E. Maletsky · Highland Park, ILDirectorAlan E. Mitrani · TEANECK, NJExecDavid A. Kornbluth · Orange Village, OHExecGordon A. Schaeffer · Santa Fe, NMExec · DirectorJeffrey M. Drazan · SAN MATEO, CADirectorKenneth C. Largess · Boston, MAExec · DirectorHamish H. Burt · New York, NYExecJonathan Friesel · New York, NYExecScott Radell · San Francisco, CADirectorNicholas Kalaitzandonakes · Maryland Heights, MOExecW. K. Grant · Denver, COExecJean A. Sabatier · EDEN PRAIRIE, MNDirectorJennifer L. Grunberg · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗